Estrogen, acting through estrogen receptors, was found extensively dysregulated during the development and progression of different cancers [22,23,24], including pancreatic cancer, where the potential mechanisms of ESR signaling are still poorly understood [25]. This evidence concerns the gene ESR1 and familial pancreatic carcinoma.